REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07222761 updates: 1. completion date: 2034-09-17 → 2034-08-23 2. primary completion date: 2029-06-15 → 2029-05-21
Clinical trial NCT07222761 updates: 1. completion date: 2034-09-17 → 2034-08-23 2. primary completion date: 2029-06-15 → 2029-05-21
Clinical trial NCT06958315 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 200 → 198 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05231122 updates: 1. completion date: 2026-12-30 → 2027-03-15 2. primary completion date: 2026-12-30 → 2027-03-15
Clinical trial NCT07543120 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-07
Clinical trial NCT06857084 updates: 1. completion date: 2027-12-31 → 2029-12-31 2. primary completion date: 2025-12-31 → 2029-12-31 3. collaborators removed: Smith & Nephew Asia Pacific Pte
Clinical trial NCT04453436: completion date: 2025-10-01 → 2026-10-31.
Clinical trial NCT07527221 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-30 → 2026-04-16
Clinical trial NCT06315582 updates: 1. completion date: 2026-10-26 → 2026-12-01 2. primary completion date: 2026-08-26 → 2026-12-01
Clinical trial NCT05174221: start date: 2022-11-09 → 2022-08-16.
Clinical trial NCT06754046: collaborators added: University of Michigan.